🇺🇸 FDA
Patent

US 9402879

Methods and compositions for modulating PD1

granted A61KA61K38/1709A61K40/11

Quick answer

US patent 9402879 (Methods and compositions for modulating PD1) held by Sangamo Biosciences, Inc. expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/1709, A61K40/11, A61K40/22, A61K40/416